![](/img/cover-not-exists.png)
Sagopilone (ZK-EPO) inhibits bone destruction and tumor burden more efficiently than paclitaxel in a mouse model of established breast cancer bone metastasis
Anne Strube, Elizaveta Stepina, Ulrich Klar, Peter Hauff, Jens Hoffmann, Sanna-Maria KäkönenVolume:
42
Year:
2008
Language:
english
Pages:
1
DOI:
10.1016/j.bone.2007.12.210
File:
PDF, 59 KB
english, 2008